Element Biosciences raises over $277 million
Element Biosciences has announced over $277 million in Series D investment to support continued development of its DNA sequencing and multi-omics technologies. The oversubscribed round was led by Wellington Management with participation from new and existing investors, including Samsung Electronics, Fidelity, Foresite Capital, funds and accounts… Read More